All News

On the heels of various reports that have highlighted the challenges of treating back pain, Palmer College of Chiropractic and Gallup released their fourth annual survey of attitudes about and experiences with chiropractic care. The 2018 Gallup-Palmer College of Chiropractic Annual Report: Managing Neck and Back Pain in America is the latest effort by the college to see if public perceptions of chiropractic care match the ones held internally.

In the United States, an estimated 40% to 75% of women have experienced sexual harassment in the workplace, and an estimated 36% of women have experienced sexual assault. At the same time as lawmakers are addressing sexual assault allegations against Supreme Court nominee Judge Brett Kavanaugh, 2 new papers, published in JAMA Internal Medicine, highlight the prevalence and health impacts that harassment and assault can have.

For 2017, New Jersey's largest insurer made particularly good progress in certain diabetes measures and in cancer screenings.

Two studies presented at the 2018 Infectious Disease Week conference held in San Francisco, California, add to a pile of research demonstrating the positive impact of collaborative, multidisciplinary care in the HIV population, specifically on viral suppression.

A once-weekly dose of carfilzomib (Kyprolis) in combination with dexamethasone has been approved to treat patients with relapsed or refractory (R/R) multiple myeloma. The approved regimen improved progression-free survival and had a better overall response rate than a twice-weekly regimen.

Patients who receive an antibiotic prescription report being happiest with their doctor’s visit, whether or not they needed the antibiotic; the FDA has collected more than 1000 pages of documents from Juul’s headquarters as part of a surprise inspection into its sales and marketing practices; on any given day, an average of 36.6% of American adults are eating fast food, and the proportion eating fast food increases with income.

Improvements in chimeric antigen receptor (CAR) T-cell therapy, approved last year by the FDA for leukemias and lymphomas, were a focus of a session by a National Cancer Institute (NCI) researcher who spoke at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference taking place in New York City this week.

A recent open-label, single-arm, phase 2 study sought to assess evaluate an alternative dosing regimen for adults myelofibrosis (MF) to assess whether such a regimen could mitigate anemia.

While the integration of social determinants of health (SDOH) into electronic health records (EHRs) may be feasible, substantial barriers to adoption exist.

A new study has found that people living with HIV are at an increased risk of both first and second primary cancer incidence.

Nobel Prize winner James Allison, PhD, pioneering T-cell researcher, said the award represents the triumph of science and shows the value of research, even if it does not immediately lead to a scientific or commercial success.

A test that uses next-generation sequencing (NGS) has been approved to detect and monitor minimal residual disease in patients with multiple myeloma (MM) and B-cell acute lymphoblastic leukemia (ALL).

James P. Allison, PhD, and Tasuku Honjo, MD, PhD, led the basic science experiments that showed the potential of checkpoint inhibitors, creating a fourth pillar in the treatment of cancer.

A single leukemia cell was able to reproduce and cause a deadly relapse of pediatric B-cell acute lymphoblastic leukemia (ALL) after it had bonded with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient. The case of the cell that became resistant to CAR T-cell therapy was published in the journal Nature Medicine Monday.

Senators Orrin Hatch, R-Utah, and Michael Bennet, D-Colorado, have introduced a new bill that would allow the FDA to include off-label uses on certain generic drug labels; in the 2017-2018 flu season, influenza killed 80,000 Americans, easily surpassing the previous record of 56,000 deaths for a regular flu season; in the last 4 years, the number of babies born with syphilis has more than doubled, reaching a 20-year high.

Antibiotic treatment may be a feasible alternative to surgery for uncomplicated acute appendicitis, according to findings from a 5-year observational follow-up study that compared appendectomy with antibiotic treatment.

Here are the top 5 articles for the month of September.

The majority of patients who suffer from migraine experience premonitory symptoms and are able to predict at least 1 attack, according to a new study.

Not only do physician-group accountable care organizations (ACOs) save Medicare more money than hospital-integrated ACOs, but the savings of physician ACOs grew substantially over 3 years.

Loyola University Chicago and Loyola Medicine announced plans this week to develop their own chimeric antigen receptor T-cells that would have less toxic side effects.

Black women are more likely to be diagnosed at a later stage of breast cancer in part due to barriers to timely screening mammography, a study reported, leading to a disparity in mortality and survival outcomes.

In a review of sex hormones and their role in the development of multiple sclerosis (MS), Ysrraelit and Correale compiled multiple references to provide clinical details regarding hormones and their respective immunological mechanisms.

Earlier this week, 3 studies were released that investigated the financial difficulties seen in patients living with cancer. Such difficulties are referred to as “financial toxicity,” which was studied in patients with metastatic breast cancer and older patients, as well as the conversations about cost of care that women with breast cancer have with their physicians.

Researchers recently investigated what role exercise plays in migraine prevention and found that although exercise can trigger migraine attacks, regular exercise may have prophylactic effects on migraine frequency.

Earlier this week, drug manufacturer Astrazeneca announced the results from a phase 3 trial studying durvalumab (Imfinzi) among patients with stage III unresectable non­–small cell lung cancer (NSCLC) who did not have disease progression after concurrent chemoradiotherapy.

Patients who use inhaled steroids to control their asthma or other breathing problems may be at a greater risk for developing nontuberculous mycobacterial lung infections.

Patients with chronic obstructive pulmonary disease (COPD) often have a significant disease burden that is particularly associated with the peak incidence of exacerbation events during winter months. A review assessed previous population studies that evaluated the impact of seasonality in COPD, emphasizing the importance of understanding how all factors impact patients and where interventions can be targeted.

Implicit biases may be unconsciously formed, but they can have real impacts for patients in the healthcare system if physicians or other healthcare providers don’t take the time to recognize their own implicit biases.